American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:
“Our Chief Medical Officer, Dr. Julie Gralow, discusses ASCOQLTY25 research that’s being presented now about the importance of federal funding in cancer Clinical Trials – particularly early phase, multimodality, dose de-escalation, rare cancer, and child-focused drug and biological agent trials.
Proceed to the video attached to the post.
More posts featuring the American Society of Clinical Oncology (ASCO) on OncoDaily.